Objective: To discuss the current state of the science surrounding human pl
uripotent stem cells and to show that the derivation of such cells from don
ated preimplantation human embryos should be eligible for federal funding p
rovided that certain protections are met.
Design: A literature search focusing on the scientific aspects of pluripote
nt stem-cell research and analyses of current and past legislation and fede
ral panel recommendations.
Conclusion(s): The current federal laws regulating the permissions necessar
y to obtain fetal tissue from elective pregnancy terminations are intended
to insulate the decision to terminate a pregnancy from the potential positi
ve influence of fetal tissue transplantation. A similar situation can be cr
eated for the derivation of cells from excess preimplantation human embryos
produced by IVF programs. If, as in fetal tissue research, assurances can
be made that the research will have no influence on the decision to dispose
of the embryo, the derivation of pluripotent stem cells from embryo should
proceed with federal funding. (Fertil Steril(R) 2000;74: 1-7. (C) 2000 by
American Society for Reproductive Medicine).